In the face of multiple failures, the company is changing its strategy.
I bought a bunch of November calls on ASTR at fourteen bucks each as lottery tickets after the most recent failure, when the stock price fell to a buck and a half, on the hope that the next launch this summer would be successful. Now they may expire worthless, and I’ll lose about three hundred bucks. But November is still three months away, and the stock could still rally on news.
The NIH, CDC, and FDA (not to mention the Department of Agriculture) have been a public-health disaster.
This does seem promising for organ preservation, but it raises the issue (as cryonicists do) of when is someone dead? If it’s not information death, declarations are intrinsically premature, if the person can be put in an ambulance to the future.
The call out, explained.
NEPA and unions have become a very expensive luxury. But California HSR was a terrible idea even without these problems.
Thoughts on the coming age. A first of two essays.
He would have been 110 years old today. And if he was still with us, he would be appalled at the depths of economic ignorance not only being propounded, but implemented.
You must be anti-pro-life.
This is totalitarian.
Tell them what you really think, Stacy.
Masten was an alumni factory, resulting in a lot of other innovative companies. They were arguably the progenitor to SpaceX’s success at reusability. I hope they’ll be able to restructure.